2016 Annual Meeting | Hot Topics Plenary Session
| 05:30 PM - 05:45 PM |
Intraspinal Stem Cell Transplantation in ALS: Where We Are Today
Eva Feldman, MD, PhD, FAAN |
|
| 05:45 PM - 06:00 PM |
Zika Virus: Neurologic Complications of the latest Emerging Pathogen
James J. Sejvar, MD, FAAN |
|
| 06:00 PM - 06:15 PM |
Recent Progress in Brain-Computer Interfaces
Karunesh Ganguly, MD, PhD |
|
| 06:15 PM - 06:30 PM |
Brain Lymphatics
Jonathan Kipnis, PhD |
|
| 06:30 PM - 06:45 PM |
Recent Advances in Functional Neurosurgery
Andres M. Lozano, MD |
| Andres M. Lozano, MD | Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation. |
| Jonathan Kipnis, PhD | No disclosure on file |
| Eva Feldman, MD, PhD, FAAN | The institution of Dr. Feldman has received research support from National Institutes of Health. The institution of Dr. Feldman has received research support from Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry. The institution of Dr. Feldman has received research support from Juvenile Diabetes Research Foundation. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Editorial Board Member with Journal of the Peripheral Nervous System, Experimental Neurology, Nature Neurology Reviews, Neurobiology of Disease, NeuroRx, Journal of Neurology Neurosurgery and Psychiatry, Scientific Reports, Lancet Neurology, Med (Cell Press Journal) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Editor-in-Chief with Oxford University Press Contemporary Neurology Series that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, and Chair of Section 07 with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Associate Editor with Annals of Neurology that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Governance Committee Chair with American Neurological Association that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, Chair of Section 07, Neuroscience Forum, Council Member with National Academy of Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Committee on Making ALS a Livable Disease Member with National Academy of Sciences, Engineering, and Medicine that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Member, Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) External Oversight Committee with National Institutes of Health that is relevant to AAN interests or activities. |
| James J. Sejvar, MD, FAAN | Dr. Sejvar has nothing to disclose. |
| Karunesh Ganguly, MD, PhD | No disclosure on file |